We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.43%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.01B
AUM Growth
+$319M
(+5.6%)
Cap. Flow
+$303M
Cap. Flow
% of AUM
5.05%
Top 10 Holdings %
Top 10 Hldgs %
12.12%
Holding
1,131
New
156
Increased
425
Reduced
373
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$34.8M |
| 2 |
Cigna
CI
|
+$31.8M |
| 3 |
UnitedHealth
UNH
|
+$26.4M |
| 4 |
AutoZone
AZO
|
+$24.3M |
| 5 |
Eli Lilly
LLY
|
+$21.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$34.9M |
| 2 |
McKesson
MCK
|
+$25.9M |
| 3 |
XL
XL Group Ltd.
XL
|
+$25.4M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$22M |
| 5 |
AT&T
T
|
+$17.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.15% |
| 2 | Financials | 18.28% |
| 3 | Industrials | 13.53% |
| 4 | Consumer Discretionary | 11.12% |
| 5 | Healthcare | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Eversource Energy
ES
$28.2B
| $203K | ﹤0.01% |
3,450
| – | – |
|
927
Asbury Automotive
ABG
$4.19B
| $202K | ﹤0.01% |
+2,990
| New | +$207K |
|
928
Vishay Precision Group
VPG
$1.39B
| $202K | ﹤0.01% |
+6,500
| New | +$185K |
|
929
Natera
NTRA
$37.5B
| $201K | ﹤0.01% |
+21,648
| New | +$212K |
|
|
AE
930
DELISTED
Adams Resources & Energy Inc
AE
| $201K | ﹤0.01% |
4,617
| – | – |
|
931
Inseego
INSG
$108M
| $200K | ﹤0.01% |
11,220
-1,490
| -12% | -$28K |
|
|
TNTR
932
DELISTED
Tintri, Inc. Common Stock
TNTR
| $195K | ﹤0.01% |
114,267
+89,413
| +360% | +$451K |
|
933
Dawson Geophysical
DWSN
$155M
| $193K | ﹤0.01% |
+30,067
| New | +$176K |
|
934
Kosmos Energy
KOS
$1.56B
| $193K | ﹤0.01% |
30,600
-437,339
| -93% | -$2.74M |
|
|
PTX
935
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $191K | ﹤0.01% |
79,921
+6,500
| +9% | +$16.4K |
|
936
Agilysys
AGYS
$2.78B
| $190K | ﹤0.01% |
+15,951
| New | +$190K |
|
937
Lineage Cell Therapeutics
LCTX
$257M
| $188K | ﹤0.01% |
79,811
-68,819
| -46% | -$161K |
|
|
OSG
938
DELISTED
Overseas Shipholding Group Inc.
OSG
| $186K | ﹤0.01% |
65,548
-16,300
| -20% | -$38K |
|
|
IVAC
939
DELISTED
Intevac Inc
IVAC
| $182K | ﹤0.01% |
26,305
-54,094
| -67% | -$356K |
|
|
KIN
940
DELISTED
Kindred Biosciences, Inc.
KIN
| $181K | ﹤0.01% |
+20,911
| New | +$183K |
|
|
HABT
941
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $179K | ﹤0.01% |
+20,292
| New | +$183K |
|
|
GNMX
942
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $176K | ﹤0.01% |
+87,382
| New | +$164K |
|
|
ECYT
943
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $175K | ﹤0.01% |
19,300
-87,341
| -82% | -$482K |
|
|
IPAS
944
DELISTED
Ipass Inc Common Stock
IPAS
| $172K | ﹤0.01% |
45,207
+31,917
| +240% | +$143K |
|
|
ICAD
945
DELISTED
iCAD Inc
ICAD
| $171K | ﹤0.01% |
55,414
+4,500
| +9% | +$15.4K |
|
946
LifeVantage
LFVN
$82.4M
| $166K | ﹤0.01% |
46,046
+26,094
| +131% | +$111K |
|
|
ARC
947
DELISTED
ARC Document Solutions, Inc.
ARC
| $166K | ﹤0.01% |
75,272
-46,527
| -38% | -$109K |
|
|
SNMX
948
DELISTED
Senomyx, Inc.
SNMX
| $160K | ﹤0.01% |
180,276
-10,580
| -6% | -$12.6K |
|
|
IMDZ
949
DELISTED
Immune Design Corp.
IMDZ
| $159K | ﹤0.01% |
+48,333
| New | +$171K |
|
950
QuinStreet
QNST
$870M
| $158K | ﹤0.01% |
12,355
-134,744
| -92% | -$1.58M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2018 Portfolio in Review
As of Q1 2018, Jacobs Levy Equity Management held 1,131 positions worth $6.01B, up 5.6% from $5.69B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management deployed $303M of net new capital in Q1 2018, opening 156 new positions and adding to 425 existing holdings. Its largest new stake was Cigna: 163,820 shares worth $27.5M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was ExxonMobil, an estimated $34.9M trimmed.
- Jacobs Levy Equity Management's largest Q1 2018 buy was Cigna: 163,820 shares worth $27.5M.
- Jacobs Levy Equity Management added most to Microsoft in Q1 2018, an estimated $34.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2018 reduction was ExxonMobil, cutting an estimated $34.9M.
- Jacobs Levy Equity Management fully exited XL Group Ltd. in Q1 2018, selling an estimated $25.4M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $6.01B portfolio in Q1 2018.
- Jacobs Levy Equity Management opened 156 new positions and closed 143 in Q1 2018.
- Jacobs Levy Equity Management's portfolio value rose 5.6% quarter-over-quarter to $6.01B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2018, filed 15 May 2018.